Cleared Traditional

K243566 - CardioTag™ (FDA 510(k) Clearance)

Jul 2025
Decision
246d
Days
Class 2
Risk

K243566 is an FDA 510(k) clearance for the CardioTag™. This device is classified as a Ballistocardiograph (Class II - Special Controls, product code DXR).

Submitted by Cardiosense, Inc. (Chicago, US). The FDA issued a Cleared decision on July 22, 2025, 246 days after receiving the submission on November 18, 2024.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2320.

Submission Details

510(k) Number K243566 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2024
Decision Date July 22, 2025
Days to Decision 246 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DXR - Ballistocardiograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2320